Abstract
Background
Breast cancer is the most common cancer and the primary cause of mortality due to cancer in female around the World. As a result, the aim of this research is to conduct a comprehensive systematic review and meta-analysis to determine the role of Krüppel-like factor 4 (KLF4) as the main gene expression in breast cancer tissue.
Methods
The studies used in this systematic review were selected from the articles published from up to February 1, 2020, in national and international databases including SID, WoS, Magiran, PubMed, Scopus, IranDoc, Science Direct, IranMedix as well as Google Scholar.
Results
From the systematic review, a meta-analysis was performed on 8 articles which were satisfied the inclusion criteria. The sample including 869 individuals was then selected to perform the meta-analysis. Based on the results derived from this meta-analysis, the total expression of klf4 gene in breast cancer tissue’s samples was 60.1% (95% CI: 45.1–73.4%). The highest and lowest Klf4 gene expression levels in breast cancer tissue samples were obtained 89.7% in Alabama in 2004 (95% CI: 83.7–93.7%) and 32.1% in Japan in 2016 (95% CI: 23.1–42.8%), respectively. The results showed that with increasing sample size and year of publication, klf4 gene expression was reduced in breast cancer tissue samples, which was statistically significant (P < 0.05).
Conclusion
Identifying the expression profiles of genes involved in breast cancer using its various pathway inhibitors can address many challenges for researchers and is very important for advancing cancer health and treatment.
Similar content being viewed by others
Availability of data and materials
Datasets are available through the corresponding author upon reasonable request.
Abbreviations
- KLF4:
-
Krüppel-like factor 4
- SID:
-
Scientific Information Database
- PRISMA:
-
Preferred Reporting Items for Systematic Reviews and Meta-Analysis
- IDC:
-
Invasive Ductal Carcinoma
- STROBE:
-
Strengthening the reporting of observational studies in epidemiology
References
Akbari A, Razzaghi Z, Homaee F, Khayamzadeh M, Movahedi M, Akbari ME. Parity and breastfeeding are preventive measures against breast cancer in Iranian women. Breast Cancer. 2011;18(1):51–5.
Antoniou AC, Easton D. Models of genetic susceptibility to breast cancer. Oncogene. 2006;25(43):5898–905.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA: Cancer J Clinicians. 2016;66(1):7–30.
DeSantis CE, Ma J, Goding Sauer A, Newman LA, Jemal A. Breast cancer statistics, 2017, racial disparity in mortality by state. CA: Cancer J Clinicians. 2017;67(6):439–48.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA: Cancer J Clinicians. 2019;69(1):7–34.
Galvão E, Martins L, Ibiapina J, Andrade H, Monte S. Breast cancer proteomics: a review for clinicians. J Cancer Res Clin Oncol. 2011;137(6):915–25.
Busco G, Cardone RA, Greco MR, Bellizzi A, Colella M, Antelmi E, et al. NHE1 promotes invadopodial ECM proteolysis through acidification of the peri-invadopodial space. FASEB J. 2010;24(10):3903–15.
Jazayeri SB, Saadat S, Ramezani R, Kaviani A. Incidence of primary breast cancer in Iran: Ten-year national cancer registry data report. Cancer Epidemiol. 2015;39(4):515–27.
Yori JL, Seachrist DD, Johnson E, Lozada KL, Abdul-Karim FW, Chodosh LA, et al. Krüppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer. Neoplasia (New York, NY). 2011;13(7):601.
Preiss A, Rosenberg UB, Kienlin A, Seifert E, Jäckle H. Molecular genetics of Krüppel, a gene required for segmentation of the Drosophila embryo. Nature. 1985;313(5997):27–32.
Yet S-F, McA’Nulty MM, Folta SC, Yen H-W, Yoshizumi M, Hsieh C-M, et al. Human EZF, a Krüppel-like zinc finger protein, is expressed in vascular endothelial cells and contains transcriptional activation and repression domains. J Biol Chem. 1998;273(2):1026–31.
Yori JL, Johnson E, Zhou G, Jain MK, Keri RA. Krüppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression. J Biol Chem. 2010;285(22):16854–63.
Yoon HS, Chen X, Yang VW. Krüppel-like factor 4 mediates p53-dependent G1/S cell cycle arrest in response to DNA damage. J Biol Chem. 2003;278(4):2101–5.
Liu Z, Teng L, Bailey S, Frost AR, Bland KI, LoBuglio AF, et al. Epithelial transformation by KLF4 requires Notch1 but not canonical Notch1 signaling. Cancer Biol Ther. 2009;8(19):1840–51.
Miller KA, Eklund EA, Peddinghaus ML, Cao Z, Fernandes N, Turk PW, et al. Kruppel-like factor 4 regulates laminin α3a expression in mammary epithelial cells. J Biol Chem. 2001;276(46):42863–8.
Wei D, Kanai M, Huang S, Xie K. Emerging role of KLF4 in human gastrointestinal cancer. Carcinogenesis. 2005;27(1):23–31.
Pandya AY, Talley LI, Frost AR, Fitzgerald TJ, Trivedi V, Chakravarthy M, et al. Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. Clin Cancer Res. 2004;10(8):2709–19.
Ghaleb AM, Aggarwal G, Bialkowska AB, Nandan MO, Yang VW. Notch inhibits expression of the Krüppel-like factor 4 tumor suppressor in the intestinal epithelium. Mol Cancer Res. 2008;6(12):1920–7.
McConnell BB, Yang VW. Mammalian Krüppel-like factors in health and diseases. Physiol Rev. 2010;90(4):1337–81.
Song X, Xing Y, Wu W, Cheng GH, Xiao F, Jin G, Liu Y, Zhao X. Expression of Krüppel-like factor 4 in breast cancer tissues and its effects on the proliferation of breast cancer MDA-MB-231 cells. Exp Ther Med. 2017;13(5):2463–7.
Hosseinpour Feizi M, Shiri Torkamani S, Babaei E, Ghanbarian M, Montazeri V, Halimi M. Investigating the KLF4 gene expression as a new molecular marker in breast tumors. J Shahid Sadoughi Univ Med Sci. 2013;21(5):599–608.
Nagata T, Shimada Y, Sekine SH, Hori R, Matsui K, Okumura T, Sawada SH, Fukuoka J, Tsukada K. Prognostic significance of NANOG and KLF4 for breast cancer. Breast Cancer. 2014;21(1):96–101.
Foster KW, Liu Z, Nail CD, Li X, Fitzgerald TJ, Bailey SK, et al. Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia. Oncogene. 2005;24:1491–500.
Nagata T, Shimada Y, Sekine SH, Moriyama M, Hashimoto I, Matsui K, Okumura T, Hori T, Imura J, Tsukada K. KLF4 and NANOG are prognostic biomarkers for triple-negative breast cancer. Breast Cancer. 2017;24(2):326–3357.
Dong MJ, Wang LB, Jiang ZHN, Jin M, Hu WX, Shen JG. The transcription factor KLF4 as an independent predictive marker for pathologic complete remission in breast cancer neoadjuvant chemotherapy: a case-control study. Onco Targets Ther. 2014;7:1963–9.
Hu W, Hofstetter WL, Li H, Zhou Y, He Y, Pataer A, et al. Putative tumor-suppressive function of Krüppel-like factor 4 in primary lung carcinoma. Clinical Cancer Research. 2009;15(18):5688–95
Choi BJ, Cho YG, Song JW, Kim CJ, Kim SY, Nam SW, et al. Altered expression of the KLF4 in colorectal cancers. Pathol-Res Pract. 2006;202(8):585–9.
Chen Y-J, Wu C-Y, Chang C-C, Ma C-J, Li M-C, Chen C-M. Nuclear Krüppel-like factor 4 expression is associated with human skin squamous cell carcinoma progression and metastasis. Cancer Biol Ther. 2008;7(5):777–82.
Tai SK, Yang MH, Chang SY, Chang YC, Li WY, Tsai TL, et al. Persistent Krüppel-like factor 4 expression predicts progression and poor prognosis of head and neck squamous cell carcinoma. Cancer Sci. 2011;102(4):895–902.
DeBellis A. Breast cancer SPORE funds research of leading-edge Tretments. Birmingham Medical News; 2009.
Acknowledgements
The authors thank the Student Research Committee, Kermanshah University of Medical Sciences.
Funding
By Deputy for Research and Technology, Kermanshah University of Medical Sciences (IR) (3010779). This deputy has no role in the study process.
Author information
Authors and Affiliations
Contributions
NS and KM, MM contributed to the design. MM carried out the statistical analysis and participated in most of the study steps. SHSH, MM prepared the manuscript. SHSH and SHR1, SHR2 assisted in designing the study and helped in the interpretation of the study. All authors have read and approved the content of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics approval and consent to participate
Ethics approval was received from the ethics committee of deputy of research and technology, Kermanshah University of Medical Sciences (3010779).
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Salari, N., Rasoulpoor, S., Rasoulpoor, S. et al. The Role of Krüppel-like Factor 4 (KLF4) Gene in Breast Cancer Tissue Samples: A Systematic Review and Meta-analysis. Indian J Gynecol Oncolog 20, 7 (2022). https://doi.org/10.1007/s40944-022-00605-4
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s40944-022-00605-4